How Much Did PharmaPoint Raise?
Funding & Key Investors

PharmaPoint has solidified its position in the healthcare technology sector by securing a total capital infusion of $940K. This trajectory of financial backing, highlighted by a recent strategic investment of $590K, underscores the market confidence in the company's ability to modernize pharmacy operations. By leveraging these resources, the firm continues to scale its enterprise-level solutions, ensuring that health systems and physician groups can effectively navigate the complexities of modern medication management.

What is PharmaPoint?

PharmaPoint
SoftwareHealthcare SoftwareBusiness Services

PharmaPoint operates as a sophisticated, technology-enabled pharmacy management provider, bridging the gap between outpatient retail pharmacies and the broader care continuum. The company distinguishes itself through its proprietary XchangePoint platform, an integrated workflow management system engineered to optimize medication adherence and safety across acute, post-acute, and ambulatory care settings. By managing retail pharmacy operations for hospitals and health systems, PharmaPoint not only enhances patient satisfaction and clinical outcomes but also transforms pharmacy departments into reliable sources of ancillary revenue for their clients. Its consistent recognition as a high-growth private entity reflects its successful integration of software-driven efficiency into traditional clinical environments.

How much funding has PharmaPoint raised?

PharmaPoint has raised a total of $940K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$590K

Debt (2020): $350K with participation from PPP

Debt (2021): $590K led by PPP

Key Investors in PharmaPoint

PPP

Public-Private Partnership

What's next for PharmaPoint?

With the recent influx of capital, PharmaPoint is well-positioned to accelerate its market penetration and enhance its technological infrastructure. The strategic focus will likely center on expanding the capabilities of the XchangePoint ecosystem to address the evolving needs of at-risk patient populations. As healthcare providers increasingly prioritize value-based care, PharmaPoint's ability to reduce costs while improving medication optimization will be a critical differentiator. Future growth initiatives will likely involve deepening partnerships with large-scale health systems and potentially exploring new frontiers in digital health integration to further solidify its role as an essential partner in the healthcare delivery chain.

See full PharmaPoint company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftwareCustomer Engagement Platforms
Customer Engagement PlatformsSoftware
Content & Collaboration SoftwareSoftware
Human Resources SoftwareSoftware

Frequently Asked Questions Regarding PharmaPoint Financial Insights

What are the most recent funding rounds that PharmaPoint has completed, and what were the funding rounds?
PharmaPoint has recently completed 2 funding rounds: Debt on Feb 26, 2021, Debt on Apr 14, 2020.
What is the total amount of funding PharmaPoint has raised to date?
PharmaPoint has raised a total of $940K in funding to date.
How many funding rounds has PharmaPoint completed?
PharmaPoint has completed 2 funding rounds.
How much funding did PharmaPoint raise in its most recent funding round?
PharmaPoint raised $590K in its most recent funding round.
Who are the lead investors in PharmaPoint's latest funding round?
The lead investor in PharmaPoint's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PharmaPoint's history?
The largest funding round in PharmaPoint's history was $590K.
See more information about PharmaPoint